Anthropic investor Lonsdale says AI firms stoking fear to sway policy
Joe Lonsdale, an investor in Anthropic and co-founder of Palantir, stated that some leading AI companies are intentionally stoking fear regarding existential risks. He argues these warnings are a dangerous tactic to influence public policy. Lonsdale's comments reveal growing tension between AI developers and investors over regulatory approaches. This perspective offers a counterpoint to the prevailing narratives from some prominent AI figures.
Joe Lonsdale's claim that AI firms are 'stoking fear to sway policy' cuts through the hype. It frames the existential risk narrative as a calculated political play. This view from an Anthropic investor suggests a deeper internal debate within the AI industry than often presented publicly. It challenges the idea that all major players are aligned on the severity or nature of AI risks.
For Asia, this reframe matters. Regulators in markets like Singapore and South Korea are developing AI frameworks. They must discern genuine technical risks from industry lobbying. If Lonsdale is correct, Asian policymakers need to be wary of narratives designed to create regulatory moats for incumbent players. This could slow innovation for smaller, emerging AI firms across the region.
The thing to watch is how quickly Asian regulators move on specific AI legislation. If they adopt broad, restrictive policies based on existential risk, it suggests the fear narrative gained traction. A more nuanced, pro-innovation approach, perhaps targeting specific applications rather than general capabilities, would indicate a more critical assessment of industry claims.
Related reading
6 stories
Trump and Chinese president Xi end summit without major agreement on AI
This article explores how AI policy discussions between global leaders often end without major agreement, echoing Lonsdale's point.

Anthropic's Tussle With Trump Administration Faces Fresh Legal Setback
We previously covered Anthropic's own tussles with the Trump administration, showing the political dimension of AI development.

How Alibaba is using AI to revamp its mapping app – and take on Meituan

China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts

Pinglu Canal underscores China’s turn toward Southeast Asia

